AbCellera Biologics Inc. ABCL Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s accumulated depreciation?
- AbCellera Biologics Inc. (ABCL) reported accumulated depreciation of $31.86M in Q1 2026.
- How has AbCellera Biologics Inc.'s accumulated depreciation changed year-over-year?
- AbCellera Biologics Inc.'s accumulated depreciation decreased by 36.2% year-over-year, from $49.94M to $31.86M.
- What is the long-term trend for AbCellera Biologics Inc.'s accumulated depreciation?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s accumulated depreciation has grown at a 18.8% compound annual growth rate (CAGR), from $18.48M to $30.94M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.